본문 바로가기
KERD
논문KCI 등재

Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report

Marco Lamberti|Gabriella Di Rosa|Francesca Cucinotta|Erica Pironti|Cecilia Galati|Antonella Gagliano
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2017.08|Clinical Psychopharmacology and Neuroscience|제15권 제3호|pp. 285-287|DOI https://doi.org/10.9758/cpn.2017.15.3.285

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

PediatricsAntipsychoticsDrug side effectsMovement disordersTardive dyskineisa

초록

In the last years second-generation antipsychotics are increasingly prescribed in the pediatric population for the treatment of several psychiatric disorders. Among the long term adverse effects, extrapyramidal symptoms (EPS) are less reported compared to first-generation antipsychotics. Tardive dyskinesia (TD) is a iatrogenic rare syndrome characterized by persistent slow writhing and sudden involuntary movements mainly involving the oral-buccal-lingual area with masticatory movements. We report a young girl with mood disorders accompanied by mild intellectual disability and behavioral problems who had TD after treatment with Aripiprazole, which responded to Biperiden therapy.

Abstract

In the last years second-generation antipsychotics are increasingly prescribed in the pediatric population for the treatment of several psychiatric disorders. Among the long term adverse effects, extrapyramidal symptoms (EPS) are less reported compared to first-generation antipsychotics. Tardive dyskinesia (TD) is a iatrogenic rare syndrome characterized by persistent slow writhing and sudden involuntary movements mainly involving the oral-buccal-lingual area with masticatory movements. We report a young girl with mood disorders accompanied by mild intellectual disability and behavioral problems who had TD after treatment with Aripiprazole, which responded to Biperiden therapy.

참고문헌 (23)

  1. Aia PG, "Tardive dyskinesia", Curr Treat Options Neurol, 13, pp.231~241 (2011)
  2. Margolese HC, "Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia", Can J Psychiatry, 50, pp.703~714 (2005)
  3. Schwartz T, "Aripiprazole(abilify)and tardive dyskinesia", P T, 33, pp.32~34 (2008)
  4. Novick D, "Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia : thirty-six-month results from the European schizophrenia outpatient health outcomes study", J Clin Psychopharmacol, 30, pp.531~540 (2010)
  5. Baldessarini RJ, "Incidence of extrapyramidal syndromes and tardive dyskinesia", J Clin Psychopharmacol, 31, pp.382~384 (2011)
  6. Correll CU, "Lower risk for tardive dyskinesia associated with second-generation antipsychotics : a systematic review of 1-year studies", Am J Psychiatry, 161, pp.414~425 (2004)
  7. Shapiro DA, "Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology", Neuropsychopharmacology, 28, pp.1400~1411 (2003)
  8. Di Sciascio G, "Aripiprazole : from pharmacological profile to clinical use", Neuropsychiatr Dis Treat, 11, pp.2635~2647 (2015)
  9. Rakesh Goyal, "A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow Up", Clinical Psychopharmacology and Neuroscience, 12(1), pp.69~71 (2014), 대한정신약물학회
  10. Lim HK, "Tardive dystonic symptoms associated with aripiprazole treatment", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.589~590 (2008)
  11. Moseley CN, "Covert dyskinesia associated with aripiprazole : a case report and review of the literature", Clin Neuropharmacol, 36, pp.128~130 (2013)
  12. Patra S, "Tardive dyskinesia and covert dyskinesia with aripiprazole : a case series", Curr Drug Saf, 11, pp.102~103 (2016)
  13. Wang LJ, "Courses of aripiprazoleassociated tardive dyskinesia : report of two cases", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.743~744 (2009)
  14. Correll CU, "Tardive dyskinesia and new antipsychotics", Curr Opin Psychiatry, 21, pp.151~156 (2008)
  15. Peña MS, "Tardive dyskinesia and other movement disorders secondary to aripiprazole", Mov Disord, 26, pp.147~152 (2011)
  16. Weiden PJ, "EPS profiles : the atypical antipsychotics are not all the same", J Psychiatr Pract, 13, pp.13~24 (2007)
  17. Na-Ri Kang, "Tardive Dyskinesia: Treatment with Aripiprazole", Clinical Psychopharmacology and Neuroscience, 9(1), pp.1~8 (2011), 대한정신약물학회
  18. Lykouras L, "Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.1535~1536 (2007)
  19. Osorio RS, "Treatment of tardive dyskinesia with aripiprazole", Neurotox Res, 17, pp.432~434 (2010)
  20. Mamo D, "Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study", Am J Psychiatry, 164, pp.1411~1417 (2007)
  21. Catena Dell'osso M, "Newer antipsychotics and the rabbit syndrome", Clin Pract Epidemiol Ment Health, 3, pp.6~ (2007)
  22. Bhidayasiri R, "Evidence-based guideline: treatment of tardive syndromes:report of the Guideline Development Subcommittee of the American Academy of Neurology", Neurology, 81, pp.463~469 (2013)
  23. Caksen H, "Use of biperiden hydrochloride in a child with severe dyskinesia induced by phenytoin", J Child Neurol, 18, pp.494~496 (2003)

관련 논문AI추천

A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow UpRakesh Goyal, Salam Hemabati Devi대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2014 · 제12권 제1호Tardive Dystonia Related with Aripiprazole김민섭, 김성환, 이경욱, 이승엽대한신경정신의학회 · PSYCHIATRY INVESTIGATION2017 · 제14권 제3호Acute Dystonia Following a Switch in Treatment from Atomoxetine to Low-dose AripiprazoleBurge Kabukcu Basay, Ömer Başay, Önder Öztürk, Zeki Yüncü대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제2호Resolution of Tardive Dyskinesia Following a Switch from Long-Acting Injectable Risperidone to Aripiprazole김성완, 김재민, 신일선, 양수진, 윤진상, Sam-Yeon Lee대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2008 · 제6권 제2호Olanzapine-induced Concurrent Tardive Dystonia and Tardive Dyskinesia in Schizophrenia with Intellectual Disability: A Case Report최영민, Boung Chul Lee, Dong Young Lee, Guk-HeeSuh, Ihn-Geun Choi, Jee Wook Kim, So Yeon Kim대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2020 · 제18권 제4호Tardive Dyskinesia: Treatment with AripiprazoleMoon Doo Kim, Na-Ri Kang대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2011 · 제9권 제1호

이 간행물의 다른 논문 (14건)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment GuidelinesJong Hyun Jeong, Jung Goo Lee, Hee Ryung Wang, Young-Min Park, Kyung Joon Min, Se-Hoon Shim, Duk-In Jon, Won Kim, Young Sup Woo, Won-Myong Bahk, Jeong Seok Seopp. 199-209How Electroconvulsive Therapy Works?: Understanding the Neurobiological MechanismsSujita Kumar Kar, Amit Singhpp. 210-221The Relationship between the SNAP-25 Polymorphism and Omission Errors in Korean Children with Attention Deficit Hyperactivity DisorderIn-Jung Sohn, Keun-Ah Cheon, EunJooKim, Dong ho Song, Nam-Wook Kimpp. 222-228Low Retinal Dehydrogenase 1 (RALDH1) Level in Prepubertal Boys with Autism Spectrum Disorders: A Possible Link to Dopamine Dysfunction?Alexandru-Şefan Niculae, Denis Pavăl, Eleonora Dronca, Florina Rad, Ră zvan Rusu, Horaţiu Alexandru Colosi, Iuliana Dobrescupp. 229-236Evaluation of Oxidant/Antioxidant Status and Cytokine Levels in Patients with Cannabis Use DisorderErdinc Cicek, Nurten Aksoy, Ibrahim Fatih Karababa, Salih Selek, Huseyin Bayazitpp. 237-242
원문 보기